Home » Authors » Trista Morrison

Articles by Trista Morrison

Elixir Raises $46M Series C For Metabolic Disease Trials

Nov. 29, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Orexigen Closes $30M Round For Late-Stage Obesity Trials

Nov. 27, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Intradigm Raises $16M For Systemic Delivery Of RNAi

Nov. 22, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Neurotech Brings In $35M For Phase II Retinal Disease Trials

Nov. 17, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Biotech's Business Models Evolve As Industry Matures

Nov. 16, 2006

By Trista Morrison

Sofinnova Closes $375M Fund To Support Spinouts

Nov. 15, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.